Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents

Roberto Canitano, Valeria ScandurraDivision of Child Neuropsychiatry, University Hospital of Siena, Siena, ItalyAbstract: This is a review of the clinical trials investigating the efficacy and safety of risperidone in the treatment of children with autistic spectrum disorders (ASD). The main clinica...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Roberto Canitano, Valeria Scandurra
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2008
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/e4a6b97264674637b7e1c69527753fa8
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:e4a6b97264674637b7e1c69527753fa8
record_format	dspace
spelling	oai:doaj.org-article:e4a6b97264674637b7e1c69527753fa82021-12-02T02:17:49ZRisperidone in the treatment of behavioral disorders associated with autism in children and adolescents1176-63281178-2021https://doaj.org/article/e4a6b97264674637b7e1c69527753fa82008-09-01T00:00:00Zhttp://www.dovepress.com/risperidone-in-the-treatment-of-behavioral-disorders-associated-with-a-a2197https://doaj.org/toc/1176-6328https://doaj.org/toc/1178-2021Roberto Canitano, Valeria ScandurraDivision of Child Neuropsychiatry, University Hospital of Siena, Siena, ItalyAbstract: This is a review of the clinical trials investigating the efficacy and safety of risperidone in the treatment of children with autistic spectrum disorders (ASD). The main clinical characteristics are impairment in social skills, communication difficulties, repetitive movements and behaviors, including stereotypies. Pharmacotherapy is mainly directed at the so-called target symptoms, ie, behavioral disorders and the various kinds of repetitions associated with ASD. According to the available data, risperidone seems to be moderately efficacious and safe for treating behavioral disorders. 4 double blind controlled trial. 3 reanalysis studies, and 12 open studies have documented the role of risperidone in children with ASD. Controlled studies have been thoroughly considered in this review.Keywords: autism, pervasive developmental disorders, risperidone Roberto CanitanoValeria ScandurraDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2008, Iss Issue 4, Pp 723-730 (2008)
institution	DOAJ
collection	DOAJ
language	EN
topic	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
spellingShingle	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Roberto Canitano Valeria Scandurra Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents
description	Roberto Canitano, Valeria ScandurraDivision of Child Neuropsychiatry, University Hospital of Siena, Siena, ItalyAbstract: This is a review of the clinical trials investigating the efficacy and safety of risperidone in the treatment of children with autistic spectrum disorders (ASD). The main clinical characteristics are impairment in social skills, communication difficulties, repetitive movements and behaviors, including stereotypies. Pharmacotherapy is mainly directed at the so-called target symptoms, ie, behavioral disorders and the various kinds of repetitions associated with ASD. According to the available data, risperidone seems to be moderately efficacious and safe for treating behavioral disorders. 4 double blind controlled trial. 3 reanalysis studies, and 12 open studies have documented the role of risperidone in children with ASD. Controlled studies have been thoroughly considered in this review.Keywords: autism, pervasive developmental disorders, risperidone
format	article
author	Roberto Canitano Valeria Scandurra
author_facet	Roberto Canitano Valeria Scandurra
author_sort	Roberto Canitano
title	Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents
title_short	Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents
title_full	Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents
title_fullStr	Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents
title_full_unstemmed	Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents
title_sort	risperidone in the treatment of behavioral disorders associated with autism in children and adolescents
publisher	Dove Medical Press
publishDate	2008
url	https://doaj.org/article/e4a6b97264674637b7e1c69527753fa8
work_keys_str_mv	AT robertocanitano risperidoneinthetreatmentofbehavioraldisordersassociatedwithautisminchildrenandadolescents AT valeriascandurra risperidoneinthetreatmentofbehavioraldisordersassociatedwithautisminchildrenandadolescents
_version_	1718402625937866752

Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents

Ejemplares similares